Odaily Planet Daily News: According to data from MSX.COM, drug development company Sellas Life Sciences surged 220% at opening, after the company announced on Tuesday that its experimental vaccine for a blood cancer showed positive results in a late-stage clinical trial, significantly extending patients' survival time.
Sellas Life Sciences shares surged 220% at market opening
2026-11-17 14:42:02
شارك
إخلاء المسؤولية: تعود حقوق نشر هذه المقالة إلى المؤلف الأصلي ولا تمثل MyToken(www.mytokencap.com)الآراء والمواقف ؛ يرجى الاتصال بنا إذا كانت لديك أسئلة حول المحتوى وحقوق التأليف والنشر وما إلى ذلك.
حول MyToken:https://www.mytokencap.com/ar/aboutusرابط لهذه المقالة:https://www.mytokencap.com/ar/choicenews/3662799
community_x_prefix
X(https://x.com/MyTokencap)community_tg_prefixcommunity_tg_name
(https://t.me/mytokenGroup)
X(https://x.com/MyTokencap)community_tg_prefixcommunity_tg_name
(https://t.me/mytokenGroup)